DNAJB6b-enriched small extracellular vesicles decrease polyglutamine aggregation in in vitro and in vivo models of Huntington disease

Summary: Huntington disease (HD) is a devastating neurodegenerative disorder characterized by aggregation of huntingtin (HTT) protein containing expanded polyglutamine (polyQ) tracts. DNAJB6, a member of the DNAJ chaperone family, was reported to efficiently inhibit polyQ aggregation in vitro, in ce...

Full description

Bibliographic Details
Main Authors: Bhagyashree S. Joshi, Sameh A. Youssef, Reinier Bron, Alain de Bruin, Harm H. Kampinga, Inge S. Zuhorn
Format: Article
Language:English
Published: Elsevier 2021-11-01
Series:iScience
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004221012517
_version_ 1818825024490962944
author Bhagyashree S. Joshi
Sameh A. Youssef
Reinier Bron
Alain de Bruin
Harm H. Kampinga
Inge S. Zuhorn
author_facet Bhagyashree S. Joshi
Sameh A. Youssef
Reinier Bron
Alain de Bruin
Harm H. Kampinga
Inge S. Zuhorn
author_sort Bhagyashree S. Joshi
collection DOAJ
description Summary: Huntington disease (HD) is a devastating neurodegenerative disorder characterized by aggregation of huntingtin (HTT) protein containing expanded polyglutamine (polyQ) tracts. DNAJB6, a member of the DNAJ chaperone family, was reported to efficiently inhibit polyQ aggregation in vitro, in cell models, and in vivo in flies, xenopus, and mice. For the delivery of exogenous DNAJB6 to the brain, the DNAJB6 needs to be protected against (enzymatic) degradation and show good penetration into brain tissue. Here, we tested the potential of small extracellular vesicles (sEVs) derived from neural stem cells (NSCs) for delivery of DNAJB6 as anti-amyloidogenic cargo. Administration of sEVs isolated from DNAJB6-overexpressing cells to cells expressing expanded polyQ tracts suppressed HTT aggregation. Furthermore, intrathecal injection of DNAJB6-enriched sEVs into R6/2 transgenic HD mice significantly reduced mutant HTT aggregation in the brain. Taken together, our data suggest that sEV-mediated molecular chaperone delivery may hold potential to delay disease onset in HD.
first_indexed 2024-12-19T00:05:11Z
format Article
id doaj.art-7e72da794b2c4764b06ad74b280ea482
institution Directory Open Access Journal
issn 2589-0042
language English
last_indexed 2024-12-19T00:05:11Z
publishDate 2021-11-01
publisher Elsevier
record_format Article
series iScience
spelling doaj.art-7e72da794b2c4764b06ad74b280ea4822022-12-21T20:46:17ZengElsevieriScience2589-00422021-11-012411103282DNAJB6b-enriched small extracellular vesicles decrease polyglutamine aggregation in in vitro and in vivo models of Huntington diseaseBhagyashree S. Joshi0Sameh A. Youssef1Reinier Bron2Alain de Bruin3Harm H. Kampinga4Inge S. Zuhorn5Department of Biomedical Engineering, University of Groningen, University Medical Center Groningen, A. Deusinglaan 1, 9713 AV Groningen, the NetherlandsDepartment of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands; Department of Molecular Genetics, Department of Pediatrics, University Medical Center Groningen, Groningen, the NetherlandsDepartment of Biomedical Engineering, University of Groningen, University Medical Center Groningen, A. Deusinglaan 1, 9713 AV Groningen, the NetherlandsDepartment of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands; Department of Molecular Genetics, Department of Pediatrics, University Medical Center Groningen, Groningen, the NetherlandsDepartment of Biomedical Sciences of Cells and Systems, University of Groningen, University Medical Center Groningen, Groningen, the NetherlandsDepartment of Biomedical Engineering, University of Groningen, University Medical Center Groningen, A. Deusinglaan 1, 9713 AV Groningen, the Netherlands; Corresponding authorSummary: Huntington disease (HD) is a devastating neurodegenerative disorder characterized by aggregation of huntingtin (HTT) protein containing expanded polyglutamine (polyQ) tracts. DNAJB6, a member of the DNAJ chaperone family, was reported to efficiently inhibit polyQ aggregation in vitro, in cell models, and in vivo in flies, xenopus, and mice. For the delivery of exogenous DNAJB6 to the brain, the DNAJB6 needs to be protected against (enzymatic) degradation and show good penetration into brain tissue. Here, we tested the potential of small extracellular vesicles (sEVs) derived from neural stem cells (NSCs) for delivery of DNAJB6 as anti-amyloidogenic cargo. Administration of sEVs isolated from DNAJB6-overexpressing cells to cells expressing expanded polyQ tracts suppressed HTT aggregation. Furthermore, intrathecal injection of DNAJB6-enriched sEVs into R6/2 transgenic HD mice significantly reduced mutant HTT aggregation in the brain. Taken together, our data suggest that sEV-mediated molecular chaperone delivery may hold potential to delay disease onset in HD.http://www.sciencedirect.com/science/article/pii/S2589004221012517Cell biologyMolecular neuroscienceMolecular physiology
spellingShingle Bhagyashree S. Joshi
Sameh A. Youssef
Reinier Bron
Alain de Bruin
Harm H. Kampinga
Inge S. Zuhorn
DNAJB6b-enriched small extracellular vesicles decrease polyglutamine aggregation in in vitro and in vivo models of Huntington disease
iScience
Cell biology
Molecular neuroscience
Molecular physiology
title DNAJB6b-enriched small extracellular vesicles decrease polyglutamine aggregation in in vitro and in vivo models of Huntington disease
title_full DNAJB6b-enriched small extracellular vesicles decrease polyglutamine aggregation in in vitro and in vivo models of Huntington disease
title_fullStr DNAJB6b-enriched small extracellular vesicles decrease polyglutamine aggregation in in vitro and in vivo models of Huntington disease
title_full_unstemmed DNAJB6b-enriched small extracellular vesicles decrease polyglutamine aggregation in in vitro and in vivo models of Huntington disease
title_short DNAJB6b-enriched small extracellular vesicles decrease polyglutamine aggregation in in vitro and in vivo models of Huntington disease
title_sort dnajb6b enriched small extracellular vesicles decrease polyglutamine aggregation in in vitro and in vivo models of huntington disease
topic Cell biology
Molecular neuroscience
Molecular physiology
url http://www.sciencedirect.com/science/article/pii/S2589004221012517
work_keys_str_mv AT bhagyashreesjoshi dnajb6benrichedsmallextracellularvesiclesdecreasepolyglutamineaggregationininvitroandinvivomodelsofhuntingtondisease
AT samehayoussef dnajb6benrichedsmallextracellularvesiclesdecreasepolyglutamineaggregationininvitroandinvivomodelsofhuntingtondisease
AT reinierbron dnajb6benrichedsmallextracellularvesiclesdecreasepolyglutamineaggregationininvitroandinvivomodelsofhuntingtondisease
AT alaindebruin dnajb6benrichedsmallextracellularvesiclesdecreasepolyglutamineaggregationininvitroandinvivomodelsofhuntingtondisease
AT harmhkampinga dnajb6benrichedsmallextracellularvesiclesdecreasepolyglutamineaggregationininvitroandinvivomodelsofhuntingtondisease
AT ingeszuhorn dnajb6benrichedsmallextracellularvesiclesdecreasepolyglutamineaggregationininvitroandinvivomodelsofhuntingtondisease